&quot;Join us today at 10:05 a.m. PST, @LisaNijmMDJD will be presenting Phase 2 data about AZR-MD-001, the ﬁrst investigational medicine to achieve a positive sign and symptom outcome for Meibomian Gland Dysfunction. #ophthalmology #visionresearch #MGD #ASCRS2023&quot;